Towards quantitative and multiplexed in vivo functional cancer genomics

Reviews

Towards quantitative and multiplexed in vivo functional cancer genomics

Towards quantitative and multiplexed in vivo functional cancer genomics, Published online: 28 September 2018; doi:10.1038/s41576-018-0053-7

CRISPR–Cas genome editing and next-generation sequencing are driving advances in cancer modelling and functional cancer genomics. Their application to autochthonous mouse models of human cancer to generate and analyse multiplexed and/or combinatorial alterations in vivo is reviewed here.

Articles You May Like

Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
Fukushima Residents Return Despite Radiation
North Korea’s Less-Known Military Threat: Biological Weapons
Highlights for January 15, 2019
Hackers are stealing computer power to make millions in cryptocurrency

Leave a Reply

Your email address will not be published. Required fields are marked *